Clinical Trials in Denver

Showing 12621-12640 of 18,161 trials

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

NCT01343485

Planned Parenthood Federation of America's (PPFA) Medical Affairs Division will conduct a prospective, cluster randomized trial to determine which factors influence the acquisition of the second and third human papillomavirus (HPV) vaccine doses among young women ages 19 to 26. This descriptive and interventional study will provide data to assess impact of a computerized tool upon HPV vaccine series completion. The interventional aspect of this study includes determination of patient assistance and provider support programs applicable to each woman's situation as well as the implementation of a computer software system for customized patient reminders.

GARDASIL Vaccination

Planned Parenthood Federation of America365 participantsStarted Sep 2011

Glendale, Arizona, United States • Arvada, Colorado, United States • Denver, Colorado, United States +6 more locations

TERMINATED8.4 miles

Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)

NCT02769637

Mucus in the airways of patients with CF represents an area for bacteria proliferation, microbial infection and inflammation. Similar to the lung, the esophagus provides an environment for bacterial to grow. The overall goal of this proposal is to characterize the esophageal microbiota of children with CF that are treated or untreated with acid blockade medication and to measure its possible impact on respiratory disease to develop novel treatment strategies.

Cystic Fibrosis

University of Colorado, Denver2 participantsStarted Sep 2017

Aurora, Colorado, United States • Aurora, Colorado, United States

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)

Find Trials by Condition in Denver

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

Pivotal Study to Evaluate the Effectiveness of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma